Skip to main content

Advertisement

Articles

Page 38 of 39

  1. Content type: Poster presentation

    Authors: Trine Z Iversen, Lotte Engell-Noerregaard, Eva Ellebaek, Rikke Andersen, Stine K Larsen, Jon Bjoern, Claus Zeyher, Cécile Gouttefangeas, Birte M Thomsen, Bente Holm, Per thor Straten, Anders Mellemgaard, Mads H Andersen and Inge M Svane

    Citation: Journal for ImmunoTherapy of Cancer 2013 1(Suppl 1):P273

    Published on:

    This article is part of a Supplement: Volume 1 Supplement 1

  2. Content type: Poster presentation

    Authors: Michelle Krogsgaard, Shi Zhong, Karolina Malecek, Laura A Johnson, Zhiya Yu, Eleazar Vega-Saenz de Miera, Farbod Darvishian, Katelyn McGary-Shipper, Kevin Huang, Joshua Boyer, Emily Corse, Yongzhao Shao, Steven A Rosenberg, Nicholas P Restifo and Iman Osman

    Citation: Journal for ImmunoTherapy of Cancer 2013 1(Suppl 1):P242

    Published on:

    This article is part of a Supplement: Volume 1 Supplement 1

  3. Content type: Poster presentation

    Authors: Erika J Schneble, John S Berry, Alfred F Trappey, Timothy J Vreeland, Diane F Hale, Alan K Sears, Guy T Clifton, Sathibalan Ponniah, Nathan M Shumway, Elizabeth A Mittendorf and George E Peoples

    Citation: Journal for ImmunoTherapy of Cancer 2013 1(Suppl 1):P236

    Published on:

    This article is part of a Supplement: Volume 1 Supplement 1

  4. Content type: Poster presentation

    Authors: Lee Krug, Alessandra di Pietro, Rajesh Narwal, Paul Robbins, Dongyue Fu, Aiman Shalabi, Ramy Ibrahim, Luana Calabro and Hedy Kindler

    Citation: Journal for ImmunoTherapy of Cancer 2013 1(Suppl 1):P132

    Published on:

    This article is part of a Supplement: Volume 1 Supplement 1

  5. Content type: Poster presentation

    Authors: Xuhui Bao, Vidyalakshmi Chandramohan, Stephen T Keir, Charles N Pegram, Roger E McLendon, Chien-Tsun Kuan, Ira H Pastan and Darell D Bigner

    Citation: Journal for ImmunoTherapy of Cancer 2013 1(Suppl 1):P126

    Published on:

    This article is part of a Supplement: Volume 1 Supplement 1

  6. Content type: Poster presentation

    Authors: Michele Sommariva, Foo Cheung, Jinguo Chen, Rongye Shi, Ling Zhang, Richard Morgan, Davide Bedognetti, Valeria De Giorgi, Maria L Ascierto, Steven A Rosenberg, Francesco M Marincola and Ena Wang

    Citation: Journal for ImmunoTherapy of Cancer 2013 1(Suppl 1):P63

    Published on:

    This article is part of a Supplement: Volume 1 Supplement 1

  7. Content type: Poster presentation

    Authors: Aaron P Rapoport, Edward A Stadtmauer, Dan T Vogl, Brendan Weiss, Gwendolyn K Binder-Scholl, Dominic P Smethurst, Jeffrey Finklestein, Irina Kulikovskaya, Minnal Gupta, Joanna E Brewer, Alan D Bennett, Andrew B Gerry, Nick J Pumphrey, Helen K Tayton-Martin, Lilliam Ribeiro, Ashraf Z Badros…

    Citation: Journal for ImmunoTherapy of Cancer 2013 1(Suppl 1):P30

    Published on:

    This article is part of a Supplement: Volume 1 Supplement 1

  8. Content type: Oral presentation

    Authors: Meredith Leong, David Kanne, Laura Glickman, Edward Lemmens, Peter Lauer, Ken Metchette, Dara Burdette, Elie Diner, Juan Fu, Kevin Soares, Dirk Brockstedt, Daniel Portnoy, Russell Vance, Young Kim, Elizabeth Jaffee, Drew Pardoll…

    Citation: Journal for ImmunoTherapy of Cancer 2013 1(Suppl 1):O20

    Published on:

    This article is part of a Supplement: Volume 1 Supplement 1

  9. Content type: Poster presentation

    Authors: Mahesh Jonnalagadda, Armen Mardiros, Lauren Hoffman, Alyssa Bernanke, Wen-Chung Chang, William Bretzlaff, Renate Starr, Xiuli Wang, Julie Ostberg, Christine Brown and Stephen J Forman

    Citation: Journal for ImmunoTherapy of Cancer 2013 1(Suppl 1):P18

    Published on:

    This article is part of a Supplement: Volume 1 Supplement 1

  10. Content type: Oral presentation

    Authors: Rahul Roychoudhuri, Kiyoshi Hirahara, Kambiz Mousavi, David Clever, Michael Bonelli, Christopher Klebanoff, Vittorio Sartorelli, Yuka Kanno, Luca Gattinoni, Ena Wang, Hui Liu, Franco Marincola, Igarashi Kazuhiko, John O’Shea and Nicholas P Restifo

    Citation: Journal for ImmunoTherapy of Cancer 2013 1(Suppl 1):O14

    Published on:

    This article is part of a Supplement: Volume 1 Supplement 1

  11. Content type: Oral presentation

    Authors: Holbrook Kohrt, Marcin Kowanetz, Scott Gettinger, John Powderly, Hartmut Koeppen, Jeffrey A Sosman, Cristina Cruz, Yuanyuan Xiao, Ahmad Mokatrin, Gregg Fine, Daniel S Chen and F Stephen Hodi

    Citation: Journal for ImmunoTherapy of Cancer 2013 1(Suppl 1):O12

    Published on:

    This article is part of a Supplement: Volume 1 Supplement 1

  12. Content type: Oral presentation

    Authors: Aizea Morales-Kastresana, Sanmamed F Miguel, Inmaculada Rodriguez, Asis Palazon, Ivan Martinez-Forero, Sara Labiano, Sandra Hervas-Stubbs, Bruno Sangro, Carmen Ochoa, Ana Rouzaut, Arantza Azpilikueta, Elixabet Bolaños, Maria Jure-Kunkel, Ines Gutgemann and Ignacio Melero

    Citation: Journal for ImmunoTherapy of Cancer 2013 1(Suppl 1):O7

    Published on:

    This article is part of a Supplement: Volume 1 Supplement 1

  13. Content type: Poster presentation

    Authors: Veronika Bachanova, Sarah Cooley, Todd Defor, Michael R Verneris, Bin Zhang, David McKenna, Julie Curtsinger, Angela Panoskaltsis-Mortari, Dixie Lewis, Keli Hippen, Philip McGlave, Daniel Weisdorf, Bruce R Blazar and Jeffrey S Miller

    Citation: Journal for ImmunoTherapy of Cancer 2013 1(Suppl 1):P1

    Published on:

    This article is part of a Supplement: Volume 1 Supplement 1

  14. Content type: Research article

    The development of immuno-oncologic agents poses unique challenges, namely that both efficacy and safety profiles differ from previously characterized cytotoxic and pathway-specific agents. In addition, expone...

    Authors: Tai-Tsang Chen

    Citation: Journal for ImmunoTherapy of Cancer 2013 1:18

    Published on:

  15. Content type: Research article

    Sub-lethal doses of radiation can alter the phenotype of target tissue by modulating gene expression and making tumor cells more susceptible to T-cell-mediated immune attack. We have previously shown that sub-...

    Authors: Anita Kumari, Ercan Cacan, Susanna F Greer and Charlie Garnett-Benson

    Citation: Journal for ImmunoTherapy of Cancer 2013 1:17

    Published on:

  16. Content type: Research article

    One of the significant tumor immune escape mechanisms and substantial barrier for successful immunotherapy is tumor-mediated inhibition of immune response through cell-to-cell or receptor/ligand interactions. ...

    Authors: Mikayel Mkrtichyan, Namju Chong, Rasha Abu Eid, Anu Wallecha, Reshma Singh, John Rothman and Samir N Khleif

    Citation: Journal for ImmunoTherapy of Cancer 2013 1:15

    Published on:

  17. Content type: Research article

    Molecular imaging with positron emission tomography (PET) may allow the non-invasive study of the pharmacodynamic effects of agonistic monoclonal antibodies (mAb) to 4-1BB (CD137). 4-1BB is a member of the tum...

    Authors: Helena Escuin-Ordinas, Mark W Elliott, Mohammad Atefi, Michelle Lee, Charles Ng, Liu Wei, Begoña Comin-Anduix, Encarnacion Montecino-Rodriguez, Earl Avramis, Caius Radu, Leslie L Sharp and Antoni Ribas

    Citation: Journal for ImmunoTherapy of Cancer 2013 1:14

    Published on:

  18. Content type: Review

    Individualized cancer therapy is a central goal of cancer biologists. Immunotherapy is a rational means to this end—because the immune system can recognize a virtually limitless number of antigens secondary to...

    Authors: Timothy J Harris and Charles G Drake

    Citation: Journal for ImmunoTherapy of Cancer 2013 1:12

    Published on:

  19. Content type: Review

    T cells can mediate remarkable tumor regressions including complete cure in patients with metastatic cancer. Genetic alterations in an individual’s cancer cells (the mutanome) encode unique peptides (m-peptide...

    Authors: Willem W Overwijk, Ena Wang, Francesco M Marincola, Hans-Georg Rammensee and Nicholas P Restifo

    Citation: Journal for ImmunoTherapy of Cancer 2013 1:11

    Published on:

  20. Content type: Review

    Myeloid Derived Suppressor Cells (MDSC) are a heterogeneous population of immature myeloid cells that are increased in states of cancer, inflammation and infection. In malignant states, MDSC are induced by tum...

    Authors: Robert Wesolowski, Joseph Markowitz and William E Carson III

    Citation: Journal for ImmunoTherapy of Cancer 2013 1:10

    Published on:

  21. Content type: Meeting report

    The Workshop associated with the 27th Annual Meeting of the Society for Immunotherapy of Cancer (SITC), North Bethesda, MD, October 24-25, 2012 focused on targeting the tumor microenvironment as part of an int...

    Authors: Melek Erdinc Sunay, Francesco Marincola, Samir N Khleif, Samuel C Silverstein, Bernard A Fox, Jerome Galon and Leisha A Emens

    Citation: Journal for ImmunoTherapy of Cancer 2013 1:9

    Published on:

  22. Content type: Research article

    CEA is expressed in >90% of pancreatic cancers (PC) and may be an appropriate immunotherapy target. CEA is poorly immunogenic due to immune tolerance; CAP1-6D, an altered peptide ligand can help bypass toleran...

    Authors: Daniel M Geynisman, Yuanyuan Zha, Rangesh Kunnavakkam, Mebea Aklilu, Daniel VT Catenacci, Blase N Polite, Cara Rosenbaum, Azadeh Namakydoust, Theodore Karrison, Thomas F Gajewski and Hedy L Kindler

    Citation: Journal for ImmunoTherapy of Cancer 2013 1:8

    Published on:

  23. Content type: Research article

    We have developed a novel approach to categorize immunity in patients that uses a combination of whole blood flow cytometry and hierarchical clustering.

    Authors: Michael P Gustafson, Yi Lin, Betsy LaPlant, Courtney J Liwski, Mary L Maas, Stacy C League, Philippe R Bauer, Roshini S Abraham, Matthew K Tollefson, Eugene D Kwon, Dennis A Gastineau and Allan B Dietz

    Citation: Journal for ImmunoTherapy of Cancer 2013 1:7

    Published on:

  24. Content type: Meeting report

    The Society for Immunotherapy of Cancer (SITC) 2012 Professional Development Session was held as part of the SITC 27th Annual Meeting, Washington, DC, on October 24, 2012. The session was designed as a new opp...

    Authors: Christian M Capitini, William L Redmond and Kimberly A Shafer-Weaver

    Citation: Journal for ImmunoTherapy of Cancer 2013 1:6

    Published on:

Annual Journal Metrics

Advertisement